Evidence map›Paper›PMID 28855972›Full record

ArticleClinical epigenetics2017

Epigenetic response of imprinted domains during carcinogenesis.

Corey L Bretz, Ingeborg M Langohr, Joomyeong Kim

Open access · goldAbstract readComparative Study
In one paragraph

Article in Clinical epigenetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Corey L BretzDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803 USA.
Ingeborg M LangohrDepartment of Pathobiological Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803 USA.
Joomyeong KimDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803 USA.ORCID 0000-0001-6577-5526
Louisiana State University · US

Funding

Imprinting studies of a paternally expressed Usp29 geneR01GM066225 · NIGMS · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI KIM, JOOMYEONG · 2004 to 2013
$2.6M
Aebp2 as an epigenetic regulator for neural crest cellR01GM097074 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KIM, JOOMYEONG · 2013 to 2016
$1.1M
NIGMS NIH HHS R01 GM066225NIGMS NIH HHS R01 GM097074
6 · The paper itself

Abstract

backgroundImprinted domains have been identified as targets for aberrant DNA methylation during carcinogenesis, but it remains unclear when these epigenetic alterations occur and how they contribute to tumor progression. Epigenetic instability at key

resultsWe report that imprinted domains remain stable in benign processes but are highly susceptible to epigenetic alterations in infiltrative lesions. The preservation of DNA methylation within imprinted domains in benign tumors throughout their duration suggests that imprinted genes are not involved with the initiation of carcinogenesis or the growth of tumors. However, the frequent detection of DNA methylation changes at imprinting control regions in infiltrative lesions suggest that imprinted genes are associated with tumor cells gaining the ability to defy tissue boundaries.

conclusionOverall, this study demonstrates that imprinted domains are targeted for DNA hypermethylation when benign tumor cells transition to malignant. Thus, monitoring DNA methylation within imprinted domains may be useful in evaluating the progression of neoplasms.

Indexed as

DNA MethylationGenomic ImprintingAnimalsCell Transformation, NeoplasticEpigenesis, GeneticHumansMiceMutationNeoplasms, ExperimentalProto-Oncogene Proteins p21(ras)Regulatory Elements, TranscriptionalKRAS protein, humanProto-Oncogene Proteins p21(ras)CancerCarcinogenesisDNA methylationGenomic imprintingImprinted genesImprinting control regionsSquamous papillomaT cell lymphoma

Identifiers

PMID28855972
PMCPMC5572065
OpenAlexW2749354404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.